{"id":291475,"date":"2024-10-19T19:47:28","date_gmt":"2024-10-19T19:47:28","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-22442-12015-tc\/"},"modified":"2024-10-25T16:49:50","modified_gmt":"2024-10-25T16:49:50","slug":"bs-en-iso-22442-12015-tc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-22442-12015-tc\/","title":{"rendered":"BS EN ISO 22442-1:2015 – TC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | compares BS EN ISO 22442-1:2015 <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | TRACKED CHANGES Text example 1 \u2014 indicates added text (in green) <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | European foreword <\/td>\n<\/tr>\n | ||||||
49<\/td>\n | Relationship between this European Standard and the Essential Requirements of EU Directive 93\/42\/EEC <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
53<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
55<\/td>\n | 1\tScope 2\tNormative references <\/td>\n<\/tr>\n | ||||||
56<\/td>\n | 3\tTerms and definitions <\/td>\n<\/tr>\n | ||||||
57<\/td>\n | 4\tRisk management process 4.1\tGeneral 4.2\tRisk analysis 4.2.1\tIdentification of qualitative and quantitative characteristics related to the safety of medical devices <\/td>\n<\/tr>\n | ||||||
58<\/td>\n | 4.2.2\tIdentification of hazards and hazardous situations <\/td>\n<\/tr>\n | ||||||
59<\/td>\n | 4.3\tRisk evaluation 4.4\tRisk control 4.4.1\tGeneral 4.4.2\tRisk control for viruses and TSE agents 4.4.3\tRisk control of other hazards <\/td>\n<\/tr>\n | ||||||
60<\/td>\n | 4.4.4\tResidual risk evaluation 4.5\tEvaluation of overall residual risk acceptability 4.5.1\tGeneral 4.5.2\tDocumentation <\/td>\n<\/tr>\n | ||||||
61<\/td>\n | 4.6\tProduction and post-production information system <\/td>\n<\/tr>\n | ||||||
62<\/td>\n | Annex\u00a0A (informative) Guidance on the application of this part of ISO\u00a022442 <\/td>\n<\/tr>\n | ||||||
63<\/td>\n | Annex\u00a0B (informative) Graphical representation of part of the risk management process for medical devices utilizing animal material <\/td>\n<\/tr>\n | ||||||
65<\/td>\n | Annex\u00a0C (normative) Special requirements for some animal materials considering the risk management for TSE agents <\/td>\n<\/tr>\n | ||||||
70<\/td>\n | Annex\u00a0D (informative) Information relevant to the management of TSE risk <\/td>\n<\/tr>\n | ||||||
79<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Tracked Changes. Medical devices utilizing animal tissues and their derivatives – Application of risk management<\/b><\/p>\n |